Cancer can be cured with AstraZeneca's Covid-19 vaccine technology

According to Bloomberg , researchers from Oxford's Jenner Institute and the Ludwig Institute for Cancer Research are designing a two-dose cancer vaccine.

This vaccine uses the same technology as the vaccine against Covid-19 . The results of the study were just published in the Journal of Cancer Immunotherapy on September 3.

This cancer vaccine uses the same technology as the vaccine against Covid-19.

The vaccine will enter human trials this year, after researchers tested it in mice and found it reduced tumor size and improved survival rates.

The global vaccine industry has made remarkable progress after many resources were poured into vaccine research against Covid-19. The pandemic has seen entirely new technologies, such as mRNA, brought in to be used to combat the epidemic. It also shows huge unexplored potential in medical fields, including cancer treatment.

With the achievements that vaccine technology against Covid-19 has brought, scientists are working on pioneering methods to treat other incurable diseases, such as cancer, by letting the immune system itself. fight disease.

The vaccine that Oxford is developing will take advantage of technology from the Covid-19 vaccine to transport the genetic code, thereby stimulating the body to focus on attacking two proteins on the surface of cancer cells. It has demonstrated anti-tumor abilities.

"This new vaccine platform has the potential to revolutionize cancer treatment," said Adrian Hill, director of the Jenner Institute .